Efficacy of bupropion in the treatment of pemoline dependence

Actas Espanolas de Psiquiatria

Volumn 35, Issue 4, 2007, Pages 277-278

  Martin Morgado B ^a   Vaz Leal, F J ^a,b   Bolivar Peralvarez M ^a   Guisado Macias J A ^a  

^a HOSPITAL INFANTA CRISTINA   (Spain)

^b UNIVERSITY OF EXTREMADURA   (Spain)

Author keywords

Bupropion; Stimulants; Substance abuse

Indexed keywords

AMFEBUTAMONE; CENTRAL STIMULANT AGENT; DOPAMINE UPTAKE INHIBITOR; PEMOLINE;

ADDICTION; ARTICLE; CASE REPORT; FEMALE; HUMAN; MIDDLE AGED; TREATMENT OUTCOME;

BUPROPION; CENTRAL NERVOUS SYSTEM STIMULANTS; DOPAMINE UPTAKE INHIBITORS; FEMALE; HUMANS; MIDDLE AGED; PEMOLINE; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 34547243274     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Schweitzer JB, Cummins TK, Kant CA. Attention-deficit hyper-activity disorder. Med Clin N Am 2001;85:757-77.
2. Spencer T, Biederman J, Wilens T, Harding M, O'Donnell D, Griffin S. Pharmacotherapy of attention-deficit hyperactivity disorder across the life cycle. J Am Acad Child Adolesc Psychiatry 1996;35:409-32.
3. Wilens TE, Spencer TJ. The stimulants revisited. Child Adolesc Psychiatr Clin N Am 2000;9:573-603.
4. Bostiq JQ, Biederman J, Spencer TJ, Wilens TE, Prince JB, Monuteaux MC, et al. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short term controlled trial. J Child Adolesc Psychopharm 2000;10:205-16.
5. Cyr M, Brown CS. Current drug therapy recommendations for the treatment of attention deficit hyperactivity disorder. Drugs 1998;56:215-23.
6. Winsberg B, Barbato M. Pemoline in ADHA. J Am Acad Child Adolesc Psychiatry 1997;36:1649-50.
7. Nakamura H, Blumer JL, Reed MD. Pemoline ingestion in children: a report of five cases and review of the literature. J Clin Pharmacol 2002;42:275-82.
8. Castaneda R, Sussman N, Levy R, Trujillo M. A treatment algorithm for attention deficit hyperactivity disorder in cocaine-dependent adults: a one-year private practice study with long-acting stimulants, fluoxetine and bupropion. Subst Abus 1999;20:59-71.
9. Levy F. The dopamine theory of attention deficit hyperactivity disorder. Aust N Z J Psychiatry 1991;25:277-83.
10. Masand PS, Gupta S. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion and mirtazapine. Ann Clin Psychiatry 2002;14:175-82.